Bullish
Regentis Biomaterials (RGNT) Advances European Commercial Launch Plans for GelrinC
Regentis Biomaterials (RGNT) announced plans to initiate European surgeon training in Q3 2026 for its GelrinC knee cartilage treatment. This program, ...